Natera, Inc. (NTRA) Stock Overview

NASDAQ · Healthcare · Diagnostics & Research

✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026

$328.18
Price
$47.31B
Market Cap
—
P/E Ratio
-$1.35
EPS
$343.18
52-Week High
$157.43
52-Week Low
—
Dividend Yield
USD
Currency

About Natera, Inc.

Natera, Inc., a diagnostics company, engages in the development and commercialization of molecular testing services worldwide. It offers Signatera, a personalized ctDNA blood test for MRD assessment, early recurrence monitoring, and evaluation of treatment response in patients previously…

Source: Yahoo Finance

Sector & Industry

Natera, Inc. operates in the Healthcare sector, within the Diagnostics & Research industry group. It is listed on the NASDAQ exchange.

Natera, Inc. at a Glance

CompanyNatera, Inc.
TickerNTRA
ExchangeNASDAQ
CurrencyUSD
Price$328.18
Market cap$47.31B
P/E ratio (trailing)—
EPS (trailing)-$1.35
52-week high$343.18
52-week low$157.43
Dividend yield—
Ex-dividend date—
Beta1.53
Return on equity (ROE)-12.54%
Debt-to-equity13.09%
Average volume1.39M
Shares outstanding144.14M
SectorHealthcare
IndustryDiagnostics & Research
Employees6,135
CountryUnited States

Investing Essentials

As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.

AMAZON Healthcare Investing Reads

Evaluating pharma pipelines, devices and healthcare economics.

Check Price →
AMAZON One Up On Wall Street

Peter Lynch on how everyday investors can spot winners before the professionals do.

Check Price →
AMAZON The Intelligent Investor

Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.

Check Price →
Disclaimer: This page is for reference only. Not financial advice. Data is a snapshot and may be out of date. Always verify with a licensed broker.

Frequently Asked Questions

What is Natera, Inc.'s current P/E ratio?
Natera, Inc. (NTRA) has a trailing P/E ratio of — as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
What is Natera, Inc.'s market capitalisation?
Natera, Inc.'s market cap is $47.31B based on our latest snapshot. See how it ranks by market cap →
What is NTRA's 52-week range?
Over the past 52 weeks, NTRA has traded between $157.43 and $343.18. What does the 52-week range mean? →
How volatile is Natera, Inc. compared to the market?
Natera, Inc. has a beta of 1.53, meaning it has historically moved more than the broader market. What does beta measure? →
Does Natera, Inc. pay a dividend?
Natera, Inc. does not currently pay a dividend according to our latest data.
What exchange is NTRA listed on?
NTRA is listed on the NASDAQ. Browse all NASDAQ-listed stocks →
What sector is Natera, Inc. in?
Natera, Inc. is classified in the Healthcare sector. Compare with Healthcare peers →

Prefer raw numbers at a glance? Browse our size and reference charts for quick lookups.

Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.

Recommended Reading & Tools

AMAZON A Random Walk Down Wall Street

Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.

Check Price →
AMAZON The Psychology of Money

Morgan Housel's short lessons on behaviour, luck and long-term wealth.

Check Price →
AMAZON Common Stocks and Uncommon Profits

Philip Fisher on what makes a business worth owning for the long term.

Check Price →

Related Healthcare Stocks